𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Factors associated with the initiation of alpha-interferon treatment in Medicaid patients diagnosed with hepatitis C

✍ Scribed by J. S. Markowitz; E. M. Gutterman; D. Hodes; W. Klaskala

Book ID
108885770
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
85 KB
Volume
12
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Analysis of clinical and virological fac
Analysis of clinical and virological factors associated with response to alpha interferon therapy in chronic hepatitis C
✍ Dr. J. A. Garson; K. Whitby; R. Deaville; S. Brillanti; M. Foli; C. Masci; M. Mi πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 508 KB

## Abstract Interferon alpha (IFN‐α) therapy is currently the treatment of choice for chronic hepatitis C (HCV) infection, but it fails to achieve a sustained response in approximately 75% of those treated. The factors which determine whether or not an individual will respond to IFN‐α are uncertain

Treatment of chronic hepatitis C with ci
Treatment of chronic hepatitis C with cirrhosis with recombinant human granulocyte colony-stimulating factor plus recombinant interferon-alpha
✍ Margarita Pardo; Inmaculada Castillo; Sonia Navas; Dr. Vicente CarreΓ±o πŸ“‚ Article πŸ“… 1995 πŸ› John Wiley and Sons 🌐 English βš– 525 KB

Interferon therapy in cirrhotic patients with hepatitis C virus infection is not efficient. In an at- tempt t o improve the response rate, a pilot study using recombinant human granulocyte colonystimulating factor (rhG-CSF) alone, and in combination with recombinant interferon-alpha (rlFN), was carr